Bio-Rad Laboratories Class B
BIO.B
9 hedge funds and large institutions have $14.1M invested in Bio-Rad Laboratories Class B in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 2.45% → 2.45% (+0%)
6% less capital invested
Capital invested by funds: $15M → $14.1M (-$938K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$27.1K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$1.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$7.95K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$119 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TM
1
Tikvah Management
Charlotte,
North Carolina
| $10.8M | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $2.45M | – | – | – |
|
3
Dimensional Fund Advisors
Austin,
Texas
| $763K | – | – | – |
|
|
U
4
UBS
Zurich,
Switzerland
| $58K | +$1.31K | +11 | +2% |
|
|
GSC
5
Ground Swell Capital
Folly Beach,
South Carolina
| $26K | +$27.1K | +228 | New |
|
6
Invesco
Atlanta,
Georgia
| $11K | – | – | – |
|
|
BIT
7
BlackRock Institutional Trust
San Francisco,
California
| $5K | – | – | – |
|
|
8
Barclays
London,
United Kingdom
| $1K | -$7.95K | -67 | -92% |
|
|
9
Bank of America
Charlotte,
North Carolina
| – | -$119 | -1 | -33% |
|
BIO.B Hedge Fund Activity: Q3 2014 in Review
9 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2014, worth a combined $14.1M — down 6.2% from $15M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Ground Swell Capital, opening a new position worth an estimated $27.1K. The largest seller was Barclays, cutting an estimated $7.95K.
- 9 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2014, up from 8 in Q2 2014.
- Funds reported $14.1M of Bio-Rad Laboratories Class B stock for Q3 2014, down 6.2% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2014 was Ground Swell Capital, an estimated $27.1K added.
- The largest Bio-Rad Laboratories Class B seller in Q3 2014 was Barclays, an estimated $7.95K sold.
Based on aggregated 13F filings for Q3 2014.